Breaking Down Hangzhou Haoyue Personal Care Co., Ltd Financial Health: Key Insights for Investors

Dig into Hangzhou Haoyue Personal Care Co., Ltd. (605009.SS) as its top line accelerates-Q1 2025 revenue hit 911 million yuan (+42.42% YoY), nine-month sales reached 2.72 billion yuan (vs. 2.04 billion), and TTM revenue stands at 3.61 billion yuan (+32.43% YoY), while 2024 revenue totaled 2.93 billion yuan (+6.25%); beneath the growth, profitability shows tension with Q1 net income of 90.61 million yuan (+5.67% YoY) but nine-month net income at 203.36 million yuan down from 294.45 million (EPS 0.95 vs. 1.35), and 2024 net profit of 387.51 million yuan (-11.65%); the balance sheet mixes stability and strategic investment-debt/equity 0.45, interest coverage 6.5, cash reserve ~500 million yuan, current ratio 1.8 and quick ratio 1.2, debt-to-assets 0.35-with the 2024 acquisition of Hubei Sibao (financed mainly by ~5% equity dilution) opening the sanitary napkin segment and supporting expansion funded by equity and varied debt maturities; market metrics as of Dec 12, 2025 show a stock price of 31.42 yuan, market cap 6.71 billion, P/E 22.59 (forward P/E 20.54), P/S 1.92, dividend yield 3.86%, 52-week range 25.76-52.74, and beta 0.40-set against risks like raw material volatility, regulatory shifts, FX exposure, supply-chain disruption and industry competition, and opportunities in MENA expansion, sustainable product lines, R&D, partnerships and e-commerce that could reshape future margins and valuation.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Revenue Analysis

Hangzhou Haoyue Personal Care Co., Ltd reported strong top-line expansion across quarterly, year-to-date and trailing measures, driven by solid sales momentum and operational scale.

• Q1 2025 revenue: 911 million yuan - up 42.42% year-on-year.
• 9M 2025 revenue (through Sep 30): 2.72 billion yuan vs. 2.04 billion yuan in same period prior year.
• TTM revenue: 3.61 billion yuan - 32.43% growth versus prior 12 months.
• Full-year 2024 revenue: 2.93 billion yuan - 6.25% increase from 2023.
• Revenue per employee: ~2.05 million yuan (1,759 employees).
• Price-to-sales (P/S) ratio: 1.92.

Key revenue dynamics to note:

• Acceleration in Q1 2025 (42.42% YoY) suggests recent product or distribution traction contributing disproportionately to full-year momentum.
• TTM growth of 32.43% indicates sustained expansion beyond a single-quarter spike, with 9M sales (2.72 bn) already exceeding the prior 12-month comparable pace.
• Revenue per employee of ~2.05 million yuan reflects leverage of scale in production, sales or higher average selling prices.
• P/S of 1.92 signals the market is valuing the company at nearly two times its annual sales - an input for comparing peers and assessing growth premium.

For broader context on the company's background and business model, see: Hangzhou Haoyue Personal Care Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Profitability Metrics

• Q1 2025 net income attributable to shareholders: 90.61 million yuan (up 5.67% YoY).
• Nine months ended Sep 30, 2025 net income attributable to shareholders: 203.36 million yuan (down from 294.45 million yuan for the same period in 2024).
• Basic EPS for first nine months of 2025: 0.95 yuan (vs. 1.35 yuan in the first nine months of 2024).
• Full-year 2024 net profit attributable to parent company: 387.51 million yuan (decrease of 11.65% vs. 2023).

• Gross profit margin: maintained at a consistent level across reported periods, suggesting stable production costs and pricing strategy.
• Operating profit margin: modest fluctuations indicate active cost control and operational efficiency adjustments; variations are limited rather than structural.
• EPS trend: decline from 1.35 (9M 2024) to 0.95 (9M 2025) highlights pressure on per-share earnings despite Q1 2025 sequential improvement in net income.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Debt vs. Equity Structure

• Debt-to-equity ratio: 0.45 (moderate leverage)
• Interest coverage ratio: 6.5 (comfortable coverage of interest expenses)
• 2024 acquisition financing: primarily equity, ~5% shareholder dilution
• Capital mix: combination of short-term and long-term debt aligned with operational and expansion needs

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Liquidity and Solvency

• Improved CCC driven by faster receivable collections and optimized inventory turnover.
• Cash reserve (~¥500M) supports capital expenditures and working capital needs without urgent refinancing.
• Debt-to-assets of 0.35 implies room to absorb debt-funded growth while keeping creditor risk moderate.
• Stable credit rating reduces borrowing costs and preserves access to capital markets.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Valuation Analysis

As of December 12, 2025, Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) trades at 31.42 yuan with a market capitalization of 6.71 billion yuan. The market currently prices the stock at a moderate growth multiple, while dividend income and low volatility provide defensive characteristics.

Key valuation takeaways:

• P/E at 22.59: implies investors are willing to pay a moderate premium for current earnings; not inexpensive but not deeply overvalued relative to growth expectations.
• Forward P/E at 20.54: suggests consensus forecasts for improving earnings-discount to trailing P/E points to expected near‑term acceleration or margin recovery.
• Dividend yield of 3.86%: offers a meaningful yield for income‑oriented investors, offsetting some price appreciation risk.
• Low beta (0.40): positions the stock as defensive within a portfolio, less sensitive to market swings despite the wide 52‑week price range.

Investor scenarios to consider:

• Income investor: the 3.86% yield combined with stable dividends supports total return even if capital gains are muted.
• Growth‑value investor: forward P/E lower than trailing P/E indicates growth expectations-validate by reviewing upcoming earnings guidance and margin trends.
• Risk‑averse investor: beta 0.40 reduces portfolio volatility exposure, but the 52‑week high at 52.74 yuan shows past susceptibility to sharp moves-assess liquidity and news drivers.

For background on corporate strategy, ownership and how the company generates revenue, see: Hangzhou Haoyue Personal Care Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Risk Factors

• Currency exchange exposure - Haoyue's export-oriented operations mean foreign revenue volatility can translate directly to reported RMB results and margins. In FY2023 exports accounted for an estimated 28% of revenue; a 5% RMB appreciation versus major currencies could reduce reported revenue by roughly 1-2 percentage points and compress net margin by an estimated 30-70 bps, all else equal.

• Raw material price swings - Key inputs (surfactants, polymers, fragrance oils, packaging resins) constitute a significant portion of cost of goods sold. In 2023 gross margin averaged near 34.5%; a 10% jump in blended raw-material costs could erode gross margin by ~200-300 bps if not offset by pricing or mix changes.

• Regulatory and compliance risk - Domestic tightening on cosmetics ingredient approvals, cross-border e-commerce rules, and foreign import standards (e.g., EU REACH-like requirements) may raise compliance costs or delay product launches. Regulatory-driven product recalls or repackaging can create one-off charges and inventory write-downs.

• Competition and margin pressure - The personal care segment in China combines large multinational brands and agile local players. Market-share shifts toward premium or value channels can impact Haoyue's pricing power. In recent quarters retail-channel mix shifts contributed to volatility in blended ASPs (average selling prices).

• Supply chain disruption - Dependency on specific suppliers for specialty ingredients and concentrated packaging vendors elevates disruption risk. Global logistics shocks (container shortages, port congestion) materially increased lead times in 2021-22 and contributed to higher working capital needs; inventory days rose from ~78 days (FY2020) to ~95 days (FY2022) at industry peers.

• Economic downturns and consumer demand sensitivity - Personal care is semi-discretionary; during economic contractions consumers trade down or cut non-essential SKUs. A 3-5% decline in disposable income across core markets could translate into mid-single-digit revenue declines for exposed product categories.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - Growth Opportunities

• Acquisition impact: Hubei Sibao Group brings product SKUs, manufacturing capacity and distribution in central China-management guidance estimates an incremental RMB 150-250 million in annual revenue potential from sanitary napkins within 12-24 months post-integration.
• International expansion: Entry into Middle East & North Africa (MENA) targets markets with growing personal-care spend; MENA feminine hygiene market estimated TAM ≈ US$1.0-1.3 billion with a CAGR near 6-8% (near-term addressable share opportunity 1-3% within 3 years).
• Sustainable product lines: Launching eco-friendly pads and biodegradable packaging aligns with premiumization trends; premium SKU ASP uplift potential +10-20% versus mainstream products.
• Partnerships & JVs: Channel and licensing partnerships can accelerate shelf presence in supermarkets and modern trade while reducing working-capital strain from direct expansion.
• R&D investment: Targeting 2-4% of revenue for R&D can drive formulation and product-differentiation (e.g., breathable, hypoallergenic, biodegradable variants) and shorten time-to-market for premium SKUs.
• E‑commerce scale-up: Online penetration already growing double-digits-targeted improvements in DTC, livestreaming, and cross-border platforms could lift online revenue share from mid-teens to 25-35% in 3 years.

• Post-acquisition integration costs vs. synergies: one-time integration spend estimate RMB 30-60 million; annual cost synergies projected RMB 10-25 million from procurement and SG&A rationalization.
• Gross margin expansion via product mix shift: sanitary napkin and premium eco-SKUs could improve blended gross margin by 150-300 bps over 18-24 months.
• E‑commerce CAC and LTV dynamics: breakeven CAC horizon expected to compress to 6-9 months with improved retention and subscription models.

• Integration milestones for Hubei Sibao: SKU rationalization, combined production utilization, and channel migration timelines.
• Progress on eco-SKU launches and pricing elasticity-market acceptance and ASP lift are key to margin outlook.
• International roll-out cadence: distributor agreements, regulatory approvals, and initial order volumes in MENA and adjacent markets.
• R&D pipeline milestones and patent/claim protections for differentiated technologies.
• E‑commerce unit economics: conversion rates, repeat purchase frequency, and marketing ROI across live commerce and cross-border platforms.